Inventor
Gera Neufeld
Inventor
Haifa, IL
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12NMicroorganisms or enzymes14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10%
C12YEnzymes10%
PatentTitleYear
10,561,707Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases20209,896,490'Semaphorin 3C variants, compositions comprising said variants and methods of use thereof'20189,808,506'Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof'20179,617,347'Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis'20179,255,271'Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis'20169,155,781'Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof'20158,815,823'Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors'20148,815,824'Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis'20148,513,194'Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof'20138,389,709'Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis'20138,168,180'Methods and compositions for modulating angiogenesis'20128,163,494'Method for assessing metastatic properties of breast cancer'20128,088,735'Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof'20126,589,782'Angiogenic factor and use thereof in treating cardiovascular disease'20036,583,276'Angiogenic factors and use thereof in treating cardiovascular disease'20036,013,780'VEGF.sub.145 expression vectors'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2020Based in Haifa, IL· patent location history
2012–2020Patents assigned to TECHNION RES & DEV FOUNDATION (8)· patent assignee history
2012–2014Patents assigned to NEUFELD GERA (7)· patent assignee history
2012–2014Patents assigned to AKIRI GAL (3)· patent assignee history
2012–2014Patents assigned to GENGRINOVITCH STELA (3)· patent assignee history
2012–2015Patents assigned to RAPPAPORT FAMILY INST FOR RES (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TECHNION RES & DEV FOUNDATION | 8 | 2012–2020 |
| NEUFELD GERAself | 7 | 2012–2014 |
| AKIRI GAL | 3 | 2012–2014 |
| GENGRINOVITCH STELA | 3 | 2012–2014 |
| RAPPAPORT FAMILY INST FOR RES | 3 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Haifa, IL | 16 | 2000–2020 |